Reuters logo
2 个月前
BRIEF-CATABASIS PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL DATA ON CAT-5571
2017年6月8日 / 下午4点39分 / 2 个月前

BRIEF-CATABASIS PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL DATA ON CAT-5571

June 8 (Reuters) - Catabasis Pharmaceuticals Inc:

* CATABASIS PHARMACEUTICALS INC - ‍ANNOUNCES POSITIVE PRECLINICAL DATA ON CAT-5571, SUPPORTING ITS POTENTIAL AS AN ORAL TREATMENT FOR CYSTIC FIBROSIS​

* CATABASIS PHARMACEUTICALS -‍DATA DEMONSTRATE IMPROVED INTRACELLULAR CLEARANCE OF BACTERIA OF IMPORTANCE IN PATIENTS WITH CYSTIC FIBROSIS FOR CAT-5571​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below